Regression of smoldering myeloma with treatment of Gaucher disease

Blood Adv. 2024 Apr 9;8(7):1634-1638. doi: 10.1182/bloodadvances.2023012304.

Kevin Barley¹, Anshuman Parekh^{2

3}, Syed Salam⁴, Damodara Rao Mendu⁴, Ravi Prakash Shukla³, Deepa Vatti^{3

5}, Daniel Verina³, Chanan Stauffer⁶, Christian Salib⁴, Siraj El Jamal⁴, Julie Teruya-Feldstein⁴, Amy S Duffield⁴, Violetta V Leshchenko³, Sundar Jagannath³, Manisha Balwani⁶, Samir Parekh^{3

6

7

8}

¹ Department of Geriatrics and Palliative Care, Icahn School of Medicine at Mount Sinai, New York, NY.
² Ardsley High School, Ardsley, NY.
³ Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
⁴ Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY.
⁵ Department of Biology, New York University, New York, NY.
⁶ Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
⁷ Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
⁸ Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

No abstract available

MeSH terms